OncoMed Pharmaceuticals, Inc.
OMED0.89000.00% ( 0.0000 )
OncoMed Pharmaceuticals, Inc. (OMED)
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathway...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.8900
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- prnewswire · Apr 7 at 03:07 PM
16:06 ETOkami Medical Announces First Patient Enrolled in ALPHA Registry
- Small Caps · Mar 30 at 09:15 PM
Optiscan Submits FDA Dossier for Inspecta Imaging Device Targeting Lucrative US Veterinary Market
- Unusual Whales · Jan 27 at 07:25 AM
Obagi Medical and Alpha Aesthetic Partners collaborate in ALOHA Program with Obagi MagIQ, the first Medspa partner chosen for innovation and education.
- 36Kr · Jan 21 at 06:27 PM
Medical AI startup OpenEvidence raises $250 million, with a valuation of $12 billion
- Tip Ranks · Jan 21 at 07:54 AM
Medical AI Startup OpenEvidence Reaches $12 Billion on Rapid Doctor Adoption
